Takeda Grabs Shire At Last After Long Pursuit

Takeda and Shire see their £46bn combination bringing commercial and pipeline strengths across multiple therapeutic areas, along with opportunities for cost synergies and strengthening in key geographic markets. 

Arrow flying to target with radial motion blur
TAKEDA FINALLY HITS TARGET WITH SHIRE • Source: Shutterstock

More from Japan

More from Focus On Asia